Somerville, MA, United States of America

Wei-Dong Jiang

This inventor holds 2 USPTO granted patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Dong Jiang. Retrieved from https://idiyas.com/inventor/wei-dong-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Wei-Dong Jiang in Cancer Treatment

Introduction

Wei-Dong Jiang is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. With a total of 2 patents, his work focuses on innovative methods for treating cancer.

Latest Patents

Wei-Dong Jiang's latest patents include a method of treating cancer with a pharmaceutical composition containing a pine root (Deutero Mycetes) fungal metabolite or an analog or derivative thereof. This innovative approach aims to provide effective treatment options for cancer patients.

Career Highlights

Wei-Dong Jiang is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies in oncology.

Collaborations

Some of his notable coworkers include Zhi-Dong Jiang and Rex T Gallagher, who contribute to the collaborative efforts in research and development within the pharmaceutical industry.

Conclusion

Wei-Dong Jiang's innovative work in cancer treatment exemplifies the importance of research and development in pharmaceuticals. His contributions are paving the way for new therapeutic options that could benefit many patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…